Stimulation of tumour growth by wound-derived growth factors

British Journal of Cancer

Volumn 79, Issue 9-10, 1999, Pages 1392-1398

  Abramovitch, R ^a   Marikovsky, M ^a,b   Meir, G ^a   Neeman, M ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Angiogenesis; C6 glioma spheroid; Heparin binding epidermal growth factor; Magnetic resonance imaging; Tumour growth

Indexed keywords

CANCER GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MITOGENIC AGENT; NEUTRALIZING ANTIBODY; PLATELET DERIVED GROWTH FACTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER TRANSPLANTATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENDOTHELIUM CELL; GLIOMA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SKIN INJURY; TUMOR GROWTH; TUMOR VASCULARIZATION;

EID: 0033049405     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690223     Document Type: Article

References (24)

1. Abramovitch R, Meir G and Neeman M (1995) Neovascularization induced growth of implanted C6 glioma multicellular spheroids: magnetic resonance microimaging. Cancer Res 55: 1956-1962
2. Abramovitch R, Marikovsky M, Meir G and Neeman M (1998a) Stimulation of tumour angiogenesis by proximal wounds: spatial and temporal analysis by MRI. Br J Cancer 77: 440-447
3. Abramovitch R, Neeman M, Reich R, Stein I, Keshet E, Abraham J, Solomon A and Marikovsky M (1998b). Intercellular communication between vascular smooth muscle and endothelial cells mediated by HB-EGF and VEGF. FEBS Lett 425: 441-447
4. Abramovitch R, Frenkiel D and Neeman M (1998c) Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging. Magn Reson Med 39: 813-824
5. Bogden AE, Moreau JP and Eden PA (1997) Proliferative response of human and animal tumours to surgical wounding of normal tissues: onset, duration and inhibition. Br J Cancer 75: 1021-1027
6. Deelman HT (1927) The part played by injury and repair in the development of cancer. Br Med J 1: 872
7. Dvorak HF, Brown LF, Detmar M and Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029-1039
8. Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG and Werner S (1995) Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 270: 12607-12613
9. Higashiyama S, Abraham JA, Miller J, Fiddes JC and Klagsbrun M (1991) A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251: 936-939
10. Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield MD, Ullrich A and Schlessinger J (1985) Amplification and overexpression of the EGF receptor gene in primary human glioblastomas. Cell Sci 3(suppl): 161-172
11. Lynch SE (1991) Interactions of growth factors in tissue repair. Prog Clin Biol Res 365: 341-357
12. Marikovsky M, Breuing K, Liu PY, Eriksson E, Higashiyama S, Farber P, Abraham J and Klagsbrun M (1993) Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc Natl Acad Sci USA 90: 3889-3893
13. Marikovsky M, Vogt P, Eriksson E, Rubin JS, Taylor WG, Joachim S and Klagsbrun M (1996) Wound fluid-derived heparin-binding EGF-like growth factor (HB-EGF) is synergistic with insulin-like growth factor-1 for Balb/MK keratinocyte proliferation. J Invest Dermatol 106: 616-621
14. Moulin V (1995) Growth factors in skin wound healing. Eur J Cell Biol 68: 1-7
15. Murthy SM, Goldschmidt RA, Rao LN, Ammirati M, Buchmann T and Scanlon EF (1989) The influence of surgical trauma on experimental metastasis. Cancer 64: 2035-2044
16. Murthy MS, Summaria IJ, Miller RJ, Wyse TB, Goldschmidt RA and Scanlon EF (1991) Inhibition of tumor implantation at sites of trauma by plasminogen activators. Cancer 68: 1724-1730
17. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH and Folkman J (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79: 315-328
18. O'Reilly MS, Holmgren L, Chen C and Folkman J (1996) Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med 2: 689-692
19. Pedersen PH, Ness GO, Engebraaten O, Bjerkvig R, Lillehaug JR and Lacrum OD (1994) Heterogeneous response to the growth factors [EGF, PDGF (bb), TGF-alpha, bFGF, IL-2] on glioma spheroid growth, migration and invasion. Int J Cancer 56: 255-261
20. Peoples GE, Blotnick S, Takahashi K, Freeman MR, Klagsbrun M and Eberlein TJ (1995) T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role. Proc Natl Acad Sci USA 92: 6547-6251
21. Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG and Vertosick Jr FT (1991) Response of low-passage human malignant gliomas in vitro to stimulation and selective inhibition of growth factor-mediated pathways. J Neurosurg 75: 284-293
22. Schiffenbauer YS, Abramovitch R, Meir G, Nevo N, Holzinger M, Itin A, Keshet E and Neeman M (1997) Loss of ovarian function promotes angiogenesis in human ovarian carcinoma. Proc Natl Acad Sci USA 94: 13203-13208
23. Strawn LM, Mann E, Elliger SS, Chu LM, Germain LL, Niederfellner G, Ullrich A and Shawver LK (1994) Inhibition of glioma cell growth by a truncated platelet-derived growth factor-beta receptor. J Biol Chem 269: 21215-21222
24. Tsai JC, Goldman CK and Gillespie GY (1995) Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. J Neurosurg 82: 864-873